AlphaYouRI
Insider selling
Robert I Blum sold $7.3M of Cytokinetics Inc (CYTK) stock
Robert I Blum, President & CEO of Cytokinetics Inc (CYTK), sold 105,426 shares of CYTK stock worth $7.3M, per an SEC Form 4 filed Sep 15, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 14, 2026, 1 day before it was made public.
CYTK has moved -6.7% since the trade date, from $72.45 to $67.56 (Sep 21, 2026 close).
- Traded
- Sep 14, 2026
- Disclosed
- Sep 15, 2026
- Filing delay
- 1 day
- Price since
- -6.7%
- Role
- President & CEO
- Source
- SEC Form 4
More CYTK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.